Your browser doesn't support javascript.
loading
Host-Derived Lipids from Tuberculous Pleurisy Impair Macrophage Microbicidal-Associated Metabolic Activity.
Marín Franco, José Luis; Genoula, Melanie; Corral, Dan; Duette, Gabriel; Ferreyra, Malena; Maio, Mariano; Dolotowicz, María Belén; Aparicio-Trejo, Omar Emiliano; Patiño-Martínez, Eduardo; Charton, Alison; Métais, Arnaud; Fuentes, Federico; Soldan, Vanessa; Moraña, Eduardo José; Palmero, Domingo; Ostrowski, Matías; Schierloh, Pablo; Sánchez-Torres, Carmen; Hernández-Pando, Rogelio; Pedraza-Chaverri, José; Rombouts, Yoann; Hudrisier, Denis; Layre, Emilie; Vérollet, Christel; Maridonneau-Parini, Isabelle; Neyrolles, Olivier; Sasiain, María Del Carmen; Lugo-Villarino, Geanncarlo; Balboa, Luciana.
Afiliación
  • Marín Franco JL; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France.
  • Genoula M; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France.
  • Corral D; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Duette G; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
  • Ferreyra M; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France.
  • Maio M; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina.
  • Dolotowicz MB; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina.
  • Aparicio-Trejo OE; Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico (UNAM), Mexico City 04510, Mexico.
  • Patiño-Martínez E; Departamento de Biomedicina Molecular, CINVESTAV, Mexico City 07360, Mexico.
  • Charton A; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Métais A; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Fuentes F; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina.
  • Soldan V; METi, Centre de Biologie Intégrative, Université de Toulouse, CNRS, UPS, Toulouse 31062, France.
  • Moraña EJ; Instituto Prof. Dr. Raúl Vaccarezza, Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires C1282AFE, Argentina.
  • Palmero D; Instituto Prof. Dr. Raúl Vaccarezza, Hospital de Infecciosas Dr. F.J. Muñiz, Buenos Aires C1282AFE, Argentina.
  • Ostrowski M; Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1121ABG, Argentina.
  • Schierloh P; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France; Instituto de I+D en Bioingenieria y Bioinformática (IBB)-UNER-CONICET, Entre Ríos 3100, Argentina.
  • Sánchez-Torres C; Departamento de Biomedicina Molecular, CINVESTAV, Mexico City 07360, Mexico.
  • Hernández-Pando R; Department of Pathology, National Institute of Medical Science and Nutrition, Salzador Zubiran, Mexico City 14080, Mexico.
  • Pedraza-Chaverri J; Department of Biology, Faculty of Chemistry, National Autonomous University of Mexico (UNAM), Mexico City 04510, Mexico.
  • Rombouts Y; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Hudrisier D; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Layre E; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Vérollet C; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Maridonneau-Parini I; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Neyrolles O; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France.
  • Sasiain MDC; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France.
  • Lugo-Villarino G; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse 31077, France. Electronic address: lugo@ipbs.fr.
  • Balboa L; Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina; International Associated Laboratory (LIA) CNRS IM-TB/HIV (1167), Buenos Aires, Argentina - Toulouse, France. Electronic address: luciana_balboa@hotmail.com.
Cell Rep ; 33(13): 108547, 2020 12 29.
Article en En | MEDLINE | ID: mdl-33378679
ABSTRACT
Mycobacterium tuberculosis (Mtb) regulates the macrophage metabolic state to thrive in the host, yet the responsible mechanisms remain elusive. Macrophage activation toward the microbicidal (M1) program depends on the HIF-1α-mediated metabolic shift from oxidative phosphorylation (OXPHOS) toward glycolysis. Here, we ask whether a tuberculosis (TB) microenvironment changes the M1 macrophage metabolic state. We expose M1 macrophages to the acellular fraction of tuberculous pleural effusions (TB-PEs) and find lower glycolytic activity, accompanied by elevated levels of OXPHOS and bacillary load, compared to controls. The eicosanoid fraction of TB-PE drives these metabolic alterations. HIF-1α stabilization reverts the effect of TB-PE by restoring M1 metabolism. Furthermore, Mtb-infected mice with stabilized HIF-1α display lower bacillary loads and a pronounced M1-like metabolic profile in alveolar macrophages (AMs). Collectively, we demonstrate that lipids from a TB-associated microenvironment alter the M1 macrophage metabolic reprogramming by hampering HIF-1α functions, thereby impairing control of Mtb infection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Pleural / Subunidad alfa del Factor 1 Inducible por Hipoxia / Lípidos / Macrófagos / Mycobacterium tuberculosis Tipo de estudio: Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Rep Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis Pleural / Subunidad alfa del Factor 1 Inducible por Hipoxia / Lípidos / Macrófagos / Mycobacterium tuberculosis Tipo de estudio: Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Rep Año: 2020 Tipo del documento: Article País de afiliación: Francia